Generic name:aducanumab-avwa
Dosage form: injection, for intravenous use
Drug class:Miscellaneous central nervous system agents
What is Aduhelm?
Aduhelm is a prescription medicine used to treat people with Alzheimer’s disease.
Treatment with Aduhelm should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials.
It is not known if this medicine is safe and effective in children.
Important information
Aduhelm can cause serious side effects, including:
Amyloid Related Imaging Abnormalities or “ARIA”. ARIA is a common side effect that does not usually cause any symptoms but can be serious. It is most commonly seen as temporary swelling in areas of the brain that usually resolves over time. Some people may also have small spots of bleeding in or on the surface of the brain with the swelling. Although most people with swelling in areas of the brain do not have symptoms, some people may have symptoms, such as:
- headache
- dizziness
- nausea
- confusion
- vision changes
Your healthcare provider will do magnetic resonance imaging (MRI) scans before and during your treatment to check you for ARIA.
Call your healthcare provider or go to the nearest hospital emergency room right away if you have any of the symptoms listed above.
Before receiving Aduhelm
Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:
- are pregnant or plan to become pregnant. It is not known if Aduhelm will harm your unborn baby. Tell your healthcare provider if you become pregnant during your treatment.
- are breastfeeding or plan to breastfeed. It is not known if aducanumab-avwa (the active ingredient) passes into your breast milk. Talk to your healthcare provider about the bes..
